Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rowin

Showing results (71-80 of 209) with videos related to

Pageof 21
Sort By:
Heart Rhythm|July 28, 2020
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoringMartin S Maron, John Brush, Ethan J Rowin, et al.
The American Journal of Cardiology|July 1, 2023
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?Martin S Maron, Ethan J Rowin, Jiri Bonaventura, et al.
Journal of the American Heart Association|May 3, 2022
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic CardiomyopathyBarry J Maron, Martin S Maron, Mark V Sherrid, et al.
JACC. Heart Failure|September 1, 2018
Reply: Atrial Fibrillation in Hypertrophic CardiomyopathyMartin S Maron, James E Udelson, Ethan J Rowin, et al.
JACC. Heart Failure|April 16, 2018
Clinical Spectrum and Management of Heart Failure in Hypertrophic CardiomyopathyBarry J Maron, Ethan J Rowin, James E Udelson, et al.
JACC. Cardiovascular Imaging|January 14, 2012
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathyEthan J Rowin, Martin S Maron, John R Lesser, et al.
The American Journal of Medicine|June 1, 2022
Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical ResearchBarry J Maron, Ethan J Rowin, Shray P Ambe, et al.
Circulation|November 27, 2023
Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic CardiomyopathyEthan J Rowin, Mark S Link, Martin S Maron, et al.
Neurology|April 26, 2006
Mycophenolate mofetil in dermatomyositis: is it safe?J Rowin, A A Amato, N Deisher, et al.
JAMA Cardiology|July 21, 2016
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and PracticeBarry J Maron, Ethan J Rowin, Susan A Casey, et al.
Pageof 21

Showing results (71-80 of 209) with videos related to

Sort By:
Pageof 21
Heart Rhythm|July 28, 2020
Back to the future: Predicting sudden death in hypertrophic cardiomyopathy relying on individual risk markers and physician judgment without mathematical scoringMartin S Maron, John Brush, Ethan J Rowin, et al.
The American Journal of Cardiology|July 1, 2023
Do Implantable Cardioverter-Defibrillators Really Belong on the Athlete Field?Martin S Maron, Ethan J Rowin, Jiri Bonaventura, et al.
Journal of the American Heart Association|May 3, 2022
Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic CardiomyopathyBarry J Maron, Martin S Maron, Mark V Sherrid, et al.
JACC. Heart Failure|September 1, 2018
Reply: Atrial Fibrillation in Hypertrophic CardiomyopathyMartin S Maron, James E Udelson, Ethan J Rowin, et al.
JACC. Heart Failure|April 16, 2018
Clinical Spectrum and Management of Heart Failure in Hypertrophic CardiomyopathyBarry J Maron, Ethan J Rowin, James E Udelson, et al.
JACC. Cardiovascular Imaging|January 14, 2012
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathyEthan J Rowin, Martin S Maron, John R Lesser, et al.
The American Journal of Medicine|June 1, 2022
Changing Demographics in Hypertrophic Cardiomyopathy and Implications for Management: Clinical ResearchBarry J Maron, Ethan J Rowin, Shray P Ambe, et al.
Circulation|November 27, 2023
Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic CardiomyopathyEthan J Rowin, Mark S Link, Martin S Maron, et al.
Neurology|April 26, 2006
Mycophenolate mofetil in dermatomyositis: is it safe?J Rowin, A A Amato, N Deisher, et al.
JAMA Cardiology|July 21, 2016
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and PracticeBarry J Maron, Ethan J Rowin, Susan A Casey, et al.
Pageof 21